World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.
Click here for original story, Nanotech improves cystic fibrosis antibiotic by 100,000-fold
Source: Phys.org